Education
About Us
Working with TipRanks
Follow Us
Kevin Rakin Insider Profile
11 Followers
Kevin Rakin, Director at Ocugen, holds 5.23M shares in Elutia (Ticker: ELUT), holds 1.22M shares in Quantum-Si (Ticker: QSI), holds 46.66K shares in Oramed Pharm (Ticker: ORMP). Most recently, Kevin Rakin Bought ― shares of Elutia on Feb 02, 2026 for an estimated value of $74.20K.
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+28.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Rakin holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Rakin
Kevin Rakin's Trading History
Ocugen
Feb 11, 2019
Director
Uninformative Buy
44.91K
$1.12M
Oramed Pharm
Mar 22, 2022
Director
Informative Sell
94.00K
$152.11K
Quantum-Si
Dec 22, 2022
Director
Uninformative Sell
―
$1.13M
Elutia
Feb 02, 2026
Director, Ten Percent Owner
Informative Buy
74.20K
$6.11M
List of latest transactions for each holding click on a transaction to see Kevin Rakin's performance on stock
You May Also Like
Kevin Rakin insider profile FAQ
What is the percentage of profitable transactions made by Kevin Rakin?
The percentage of profitable transactions made by Kevin Rakin is 83%.
What is the average return per transaction made by Kevin Rakin?
The average return per transaction made by Kevin Rakin is 28.90%.
What stocks does Kevin Rakin hold?
Kevin Rakin holds: OCGN, ORMP, QSI, ELUT stocks.
What was Kevin Rakin’s latest transaction?
Kevin Rakin latest transaction was an Informative Buy of $74.20K.
What was Kevin Rakin's most profitable transaction?
Kevin Rakin’s most profitable transaction was an Informative Buy of ELUT stock on December 19, 2025. The return on the trade was 86.00%.
What is Kevin Rakin's role in Ocugen?
Kevin Rakin's role in Ocugen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.